Swiss Airtainer, an innovator in temperature-controlled air cargo containers, has secured significant pre-round A investment from private investors, building on previous multi-million dollar grants from venture capital sources. This funding aims to meet the increasing demand for their sustainable and reliable containers, already validated by major pharmaceutical companies. The containers feature lightweight materials that reduce CO2 emissions and ensure precise temperature control during transit. CEO Eduard Seligman highlighted the investment’s role in advancing their vision for innovative cold chain logistics solutions.

Source: https://www.stattimes.com/pharma/swiss-airtainer-gets-pre-round-a-funding-for-market-expansion-1353246